RDY Dr. Reddy's Laboratories Limited

NYSE
$14.77

Dr. Reddy's Laboratories Limited (RDY) is expected to report earnings on January 22, 2027, during market hours. The consensus earnings estimate is $0.15 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +9.3% since its last earnings release on October 23, 2026.

Dr. Reddy's Laboratories Limited Missed Consensus Estimates
Friday, October 23, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Dec 2026
Jan 22
Friday · Market Hours
Earnings Whisper
-
vs $0.15
Rev est $1B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $13.95

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Dr. Reddy's Laboratories Limited

Dr Reddy Laboratories Ltd together with its subsidiaries is engaged in manufacturing of pharmaceutical products. It operates through three segments; Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products.

Sector

Healthcare

Industry

Drugs - Generic

Charts powered in part by Lightweight Charts™ by TradingView.